anmelden
BX Swiss TOP 30 CHF
1.508,52
PKT
-1,02
PKT
-0,07
%
Handle Aktien, ETFs, Derivate & Kryptos ohne Ordergebühren (zzgl. Spreads) beim ‘Kostensieger’ finanzen.net zero (Stiftung Warentest 12/2025)
Werbung
Analysen zu BX Swiss TOP 30 CHF-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 08.01.13 | Lonza halten | Vontobel Research | |
| 07.01.13 | UBS kaufen | RBC Capital Markets | |
| 04.01.13 | Straumann halten | Vontobel Research | |
| 28.12.12 | UBS Verkaufen | Norddeutsche Landesbank (Nord/LB) | |
| 28.12.12 | UBS halten | Norddeutsche Landesbank (Nord/LB) | |
| 28.12.12 | Zurich Insurance kaufen | Cheuvreux SA | |
| 21.12.12 | Holcim halten | Vontobel Research | |
| 19.12.12 | Lonza hold | Vontobel Research | |
| 19.12.12 | UBS buy | Vontobel Research | |
| 18.12.12 | Holcim buy | Banc of America Securities-Merrill Lynch | |
| 18.12.12 | Holcim overweight | J.P. Morgan Cazenove | |
| 18.12.12 | Holcim neutral | Banc of America Securities-Merrill Lynch | |
| 18.12.12 | Zurich Insurance neutral | J.P. Morgan Cazenove | |
| 18.12.12 | Holcim neutral | Sarasin Research | |
| 18.12.12 | Holcim hold | Vontobel Research | |
| 17.12.12 | Holcim neutral | Citigroup Corp. | |
| 17.12.12 | Holcim buy | Citigroup Corp. | |
| 17.12.12 | Lonza hold | Vontobel Research | |
| 17.12.12 | Zurich Insurance hold | Vontobel Research | |
| 17.12.12 | Zurich Insurance neutral | Sarasin Research | |
| 17.12.12 | Holcim hold | Vontobel Research | |
| 14.12.12 | Partners Group kaufen | Sarasin Research | |
| 14.12.12 | ABB (Asea Brown Boveri) sell | Deutsche Bank AG | |
| 14.12.12 | ABB (Asea Brown Boveri) buy | Vontobel Research | |
| 14.12.12 | Zurich Insurance outperform | Sanford C. Bernstein and Co., Inc. | |
| 13.12.12 | Novartis hold | Deutsche Bank AG | |
| 13.12.12 | Sika neutral | Sarasin Research | |
| 13.12.12 | Sika hold | Vontobel Research | |
| 12.12.12 | Roche outperform | Credit Suisse Group | |
| 12.12.12 | ABB (Asea Brown Boveri) buy | UBS AG | |
| 12.12.12 | Novartis outperform | Credit Suisse Group | |
| 12.12.12 | Roche buy | Deutsche Bank AG | |
| 11.12.12 | Swiss Life buy | Sarasin Research | |
| 11.12.12 | Swisscom outperform | Exane-BNP Paribas SA | |
| 11.12.12 | Roche outperform | Exane-BNP Paribas SA | |
| 11.12.12 | UBS outperform | Exane-BNP Paribas SA | |
| 11.12.12 | Adecco SA buy | Deutsche Bank AG | |
| 11.12.12 | Roche halten | Norddeutsche Landesbank (Nord/LB) | |
| 11.12.12 | Novartis halten | Norddeutsche Landesbank (Nord/LB) | |
| 11.12.12 | Novartis reduce | Vontobel Research |
